Updated:
OpenClinica
OpenClinica is a US-based company founded in 2006 in Waltham, Massachusetts. It specializes in electronic data capture for clinical research.
OpenClinica
OpenClinica is a US-based company founded in 2006 in Waltham, Massachusetts. It specializes in electronic data capture for clinical research. The company has received no external funding.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Needham
Corporate office
Needham, MA, United States
Sector focus
Frequently asked questions
How does OpenClinica differentiate from Medidata and Oracle in clinical data capture?
OpenClinica originated as an open-source electronic data capture platform, and that licensing model remains its primary differentiator. The enterprise offering gives trial sponsors and academic centers the ability to inspect the underlying source code for audit and reproducibility purposes — something proprietary platforms do not provide. This matters to biostatistics teams and public-sector funders who must demonstrate data-provenance integrity to regulators and institutional review boards.
Which types of organizations typically adopt OpenClinica?
The user base spans pharmaceutical sponsors, medical-device manufacturers, contract research organizations, and academic medical centers running investigator-initiated trials. OpenClinica's free Community Edition historically seeded adoption in academic and public-health settings, particularly in low-resource trial environments where proprietary EDC licensing was cost-prohibitive. The enterprise platform extends that footprint into regulated commercial trial settings.
Does OpenClinica handle clinical trial data management beyond electronic case report forms?
Yes. The platform covers the full data-capture lifecycle: electronic case report form design, data entry and validation, discrepancy management, medical coding, and data export to statistical analysis environments. It also integrates with complementary clinical technology services — including randomization, electronic patient-reported outcomes, and risk-based monitoring — to form a modular data backbone for trial operations.
Is OpenClinica regulated as a medical device or a service provider by the FDA?
OpenClinica is not regulated as a medical device; it is a software platform subject to FDA 21 CFR Part 11 requirements for electronic records and signatures when used in regulated clinical trials. The firm provides validation documentation and procedural frameworks that enable sponsors to demonstrate Part 11 compliance in their specific trial implementations, consistent with industry FDA guidance on computerized systems used in clinical investigations.
Can OpenClinica data integrate with SAS or R for statistical analysis?
Yes, the platform supports data exports in CDISC-compliant formats including SAS transport files, as well as direct exports to statistical environments such as R and SAS. This is a standard interoperability requirement for any EDC operating in the regulated clinical-trial market, and OpenClinica's export architecture is designed to feed into the statistical computing environments that generate the tables, listings, and figures submitted to regulators.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: